Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

SHA:688198 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	524.14	500.26	369.91	295.07	251.8	181.9
Other Revenue	1.61	1.61	0.73	0.1	0.02	0.02
Revenue	525.75	501.88	370.64	295.17	251.82	181.92
Revenue Growth (YoY)	37.63%	35.41%	25.57%	17.21%	38.42%	24.57%
Cost of Revenue	64.65	58.52	37.64	31.36	29.61	20.21
Gross Profit	461.1	443.35	333	263.81	222.21	161.71
Selling, General & Admin	154.94	154.92	131.97	123.77	131.16	83.41
Research & Development	144.45	151.44	98.81	55.15	58.9	28.77
Other Operating Expenses	-8.09	3.46	1.25	1.62	1.17	1.06
Operating Expenses	293.66	312.22	233.5	181.64	192.04	114.69
Operating Income	167.44	131.14	99.5	82.17	30.17	47.02
Interest Expense	-0.45	-0.46	-0.41	-0.08	-0.12	-
Interest & Investment Income	16.5	17.32	17.66	22.53	16.49	19.55
Currency Exchange Gain (Loss)	0.05	0.05	-0.26	0	-	-
Other Non Operating Income (Expenses)	-3.4	-0.16	-0.06	-0.68	-0.05	-0.06
EBT Excluding Unusual Items	180.14	147.89	116.43	103.94	46.5	66.51
Gain (Loss) on Sale of Investments	0.82	0.74	1	0.89	0.97	0.34
Gain (Loss) on Sale of Assets	-0.05	-0.05	0.05	-0.01	-0.02	0.01
Other Unusual Items	-0.26	2.2	2.54	1.32	2.31	-0.57
Pretax Income	180.65	150.79	120.02	106.14	49.76	66.29
Income Tax Expense	22.22	18.64	10.61	11.74	-1.51	10.37
Earnings From Continuing Operations	158.43	132.14	109.41	94.39	51.26	55.92
Minority Interest in Earnings	12.09	14.19	5.8	0.73	-0.06	0.61
Net Income	170.51	146.33	115.21	95.13	51.2	56.53
Net Income to Common	170.51	146.33	115.21	95.13	51.2	56.53
Net Income Growth	52.48%	27.02%	21.11%	85.80%	-9.42%	-10.40%
Shares Outstanding (Basic)	136	137	136	136	135	134
Shares Outstanding (Diluted)	136	137	137	136	135	134
Shares Change (YoY)	-2.42%	-0.29%	0.92%	0.86%	0.44%	33.66%
EPS (Basic)	1.25	1.07	0.85	0.70	0.38	0.42
EPS (Diluted)	1.25	1.07	0.84	0.70	0.38	0.42
EPS Growth	56.26%	27.38%	20.00%	84.21%	-9.82%	-32.96%
Free Cash Flow	14.69	-27.02	12.53	24.01	4.27	43.07
Free Cash Flow Per Share	0.11	-0.20	0.09	0.18	0.03	0.32
Dividend Per Share	0.800	0.800	0.800	0.500	0.357	0.143
Dividend Growth	-	-	60.00%	40.02%	149.90%	-
Gross Margin	87.70%	88.34%	89.84%	89.38%	88.24%	88.89%
Operating Margin	31.85%	26.13%	26.85%	27.84%	11.98%	25.85%
Profit Margin	32.43%	29.16%	31.08%	32.23%	20.33%	31.07%
Free Cash Flow Margin	2.79%	-5.38%	3.38%	8.14%	1.70%	23.67%
EBITDA	188.78	150.45	110.7	87.78	36.19	52.69
EBITDA Margin	35.91%	29.98%	29.87%	29.74%	14.37%	28.96%
D&A For EBITDA	21.34	19.31	11.19	5.61	6.02	5.67
EBIT	167.44	131.14	99.5	82.17	30.17	47.02
EBIT Margin	31.85%	26.13%	26.85%	27.84%	11.98%	25.85%
Effective Tax Rate	12.30%	12.36%	8.84%	11.06%	-	15.64%
Revenue as Reported	525.75	501.88	370.64	295.17	251.82	181.92
Advertising Expenses	-	2.01	0.37	1.12	1.22	0.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.